UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia

Neurobiology of disease, 2021-01, Vol.148, p.105162-105162, Article 105162

2021

Volltextzugriff (PDF)

Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease

Neurobiology of disease, 2016-10, Vol.94, p.32-43

2016

Volltextzugriff (PDF)

Picalm reduction exacerbates tau pathology in a murine tauopathy model

Acta neuropathologica, 2020-04, Vol.139 (4), p.773-789

2020

Volltextzugriff (PDF)

Amyloid-[beta] pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo

Acta neuropathologica, 2019-03, Vol.137 (3), p.397

2019

Volltextzugriff (PDF)

Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo

Acta neuropathologica, 2019-03, Vol.137 (3), p.397-412

2019

Volltextzugriff (PDF)

A 4R tauopathy develops without amyloid deposits in aged cat brains

Neurobiology of aging, 2019-09, Vol.81, p.200-212

2019

Volltextzugriff (PDF)

Ten priorities for national brain and mental health plans

Croatian medical journal, 2019-04, Vol.60 (2), p.152-155

2019

Volltextzugriff (PDF)

Tau Protein as a New Regulator of Cellular Prion Protein Transcription

Molecular neurobiology, 2020-10, Vol.57 (10), p.4170-4186

2020

Volltextzugriff (PDF)

iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology

Molecular neurobiology, 2018-04, Vol.55 (4), p.3033-3048

2018

Volltextzugriff (PDF)

Domain-Specific Activation of Death-Associated Intracellular Signalling Cascades by the Cellular Prion Protein in Neuroblastoma Cells

Molecular neurobiology, 2016-09, Vol.53 (7), p.4438-4448

2016

Volltextzugriff (PDF)

Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice

Neurobiology of aging, 2013-12, Vol.34 (12), p.2793-2804

2013

Volltextzugriff (PDF)

The time course of processing handwritten words: An ERP investigation

Neuropsychologia, 2021-08, Vol.159, p.107924-107924, Article 107924

2021

Volltextzugriff (PDF)

Contribution of mesolimbic dopamine and kappa opioid systems to the transition from acute to chronic pain

Neuropharmacology, 2020-11, Vol.178, p.108226-108226, Article 108226

2020

Volltextzugriff (PDF)

Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2024-01, Vol.16 (1), p.e12467-n/a

2024

Volltextzugriff (PDF)

Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels

Journal of neurodevelopmental disorders, 2024-06, Vol.16 (1), p.33-10, Article 33

2024

Volltextzugriff (PDF)

Intracellular accumulation of a mild‐denatured monomer of the human PrP fragment 90–231, as possible mechanism of its neurotoxic effects

Journal of neurochemistry, 2007-12, Vol.103 (6), p.2597-2609

2007

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Aktive Filter

ThemaChemistry

ThemaNeurosciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia

Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease

Picalm reduction exacerbates tau pathology in a murine tauopathy model

Amyloid-[beta] pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo

Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo

A 4R tauopathy develops without amyloid deposits in aged cat brains

Ten priorities for national brain and mental health plans

Tau Protein as a New Regulator of Cellular Prion Protein Transcription

iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology

Domain-Specific Activation of Death-Associated Intracellular Signalling Cascades by the Cellular Prion Protein in Neuroblastoma Cells

Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice

The time course of processing handwritten words: An ERP investigation

Hypoxia compromises the mitochondrial metabolism of Alzheimer's disease microglia via HIF1

Contribution of mesolimbic dopamine and kappa opioid systems to the transition from acute to chronic pain

Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss

Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels

Intracellular accumulation of a mild‐denatured monomer of the human PrP fragment 90–231, as possible mechanism of its neurotoxic effects

Aktive Filter

Suchergebnisse filtern